Product Images Neurontin
View Photos of Packaging, Labels & Appearance
- Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - image 01
- Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - image 02
- Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - image 03
- Figure 4. Responder Rate in Patients Receiving NEURONTIN Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 04
- Neurontin Capsules 100 mg Bottle Label - image 05
- Neurontin Capsules 300 mg Bottle Label - image 06
- Neurontin Capsules 400 mg Bottle Label - image 07
- Neurontin Tablets 600 mg Bottle Label - image 08
- Neurontin Tablets 800 mg Bottle Label - image 09
- Neurontin Oral Solution 250 mg per 5 mL Carton Label - image 10
- Equation - neurontin 01
- Chemical Structure - neurontin 02
Product Label Images
The following 12 images provide visual information about the product associated with Neurontin NDC 58151-281 by Viatris Specialty Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Figure 1. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 1 - image 01
Figure 2. Weekly Mean Pain Scores (Observed Cases in ITT Population): Study 2 - image 02
This text seems to describe a study or experiment comparing the effects of Placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day on pain scores over a period of 7 weeks. The study measured the mean pain scores from baseline to the end of the 7-week period.*
Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - image 03
This text provides information on the proportion of responders (patients with a 50% reduction in pain score) in controlled PHN studies. It includes data from Study 1 and Study 2, comparing the percentages of responders in the different treatment groups (PBO, GBP 3600, GBP 1800, and GBP 2400).*
Figure 4. Responder Rate in Patients Receiving NEURONTIN Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 04
Neurontin Capsules 100 mg Bottle Label - image 05
Neurontin Capsules 300 mg Bottle Label - image 06
This text describes a medication called Neurontin (gabapentin) in capsule form. It mentions dosage and usage instructions, advising to refer to the package insert for complete prescribing information. Each capsule contains 300 g of active ingredient. The text also states that the medication should be dispensed without a prescription guide. It is intended for use in temperatures ranging from 15°C to 10°.*
Neurontin Capsules 400 mg Bottle Label - image 07
This is a medication label for Neurontin capsules containing 400mg of the active ingredient gabapentin. The label includes instructions for dosage and use, as well as a reminder to always dispense with a measuring guide. It also specifies that there are 100 capsules per container.*
Neurontin Tablets 600 mg Bottle Label - image 08
This text provides information about Neurontin (gabapentin) tablets, each containing 500 mg of gabapentin. It mentions that storage is at 25°C with excursions permitted to 15°C and includes directions to consult the package insert for full prescribing information. Additionally, it specifies that dosages and uses should be referred to the package insert. The packaging states "Always dispense with medication guide." This product comes in a box containing 100 tablets.*
Neurontin Tablets 800 mg Bottle Label - image 09
This text contains information about a medication called Neurontin (gabapentin) tablets. It includes details about dosage, excursions permitted for storage temperature, and the quantity of tablets in the package (100 tablets). It also mentions the importance of dispensing with the medication guide included. Additional details for Prescribing Information can be found in the package insert.*
Neurontin Oral Solution 250 mg per 5 mL Carton Label - image 10
Equation - neurontin 01
This text provides a formula to calculate creatinine clearance using weight and serum creatinine levels. The formula involves multiplying weight in kilograms by serum creatinine levels (mg/dL), along with adjusting the result by multiplying by 0.85 for female patients.*
Chemical Structure - neurontin 02
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
